Evidence-Based Medicine Guidelines
Risperidone versus placebo for schizophrenia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Risperidone Versus Placebo for Schizophrenia." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/454249/all/__________Risperidone_versus_placebo_for_schizophrenia______.
Risperidone versus placebo for schizophrenia. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. https://evidence.unboundmedicine.com/evidence/view/EBMG/454249/all/__________Risperidone_versus_placebo_for_schizophrenia______. Accessed December 4, 2024.
Risperidone versus placebo for schizophrenia. (2024). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/454249/all/__________Risperidone_versus_placebo_for_schizophrenia______
Risperidone Versus Placebo for Schizophrenia [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. [cited 2024 December 04]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/454249/all/__________Risperidone_versus_placebo_for_schizophrenia______.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Risperidone versus placebo for schizophrenia
ID - 454249
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/454249/all/__________Risperidone_versus_placebo_for_schizophrenia______
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
